Logo

Perlegen, Academic Consortium to Study SNPs Linked to Bipolar Disorder

Jul 14, 2005

NEW YORK, July 14 (GenomeWeb News) - Perlegen Sciences and the Pritzker Neuropsychiatric Disorders Research Consortium will jointly study genetic variations associated with bipolar disorder, the Mountain View, Calif.-based company said today.

 

The partners plan to genotype SNPs in patients and controls and validate the results in a separate study. PNDRC will also examine how genetic variations correlate with changes in gene expression.

 

DNA samples will come from projects that participated in the National Institute of Mental Health Bipolar Disorder Genetics Initiative, and controls from the NIMH Molecular Genetics of Schizophrenia Initiative.

 

PNDRC is a collaboration between several academic groups, including the University of Michigan, StanfordUniversity, the Universityof Californiaat Irvine, the Universityof Californiaat Davis, and CornellUniversity.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.